The global orthopedic devices market is forecasted to exceed $55 billion by 2025, according to a Global Market Insights report published on pharmaphorum.
Spinal Tech
Amplify Surgical launched its dualX earlier this year and it has now been implanted in 100 surgical levels.
The FDA cleared 31 orthopedic-related devices in September.
In a nearly decades-old case, the U.S. Supreme Court has declined to review its decision in a patent infringement case between Stryker and Zimmer Biomet.
Xtant Medical appointed Sean Browne president and CEO.
Advertisement
Cosentyx, a monoclonal antibody developed by Novartis, demonstrated positive results in treating patients with non-radiographic axial spondyloarthritis, reports PhamraLive.
Centinel Spine's prodisc L lumbar total disc replacement celebrated its 18th year of clinical usage.
Medtronic's restorative therapies group, which includes devices and implants for spine, musculoskeletal, brain and nerve conditions, will likely see its revenue steadily rise over the next few years, according to Trefis.
As physicians look for alternate ways to treat pain in the midst of the opioid crisis, neuromodulation implants for spinal cord stimulation is experiencing a significant surge, reports Business Insider.
Here are 10 key notes on spine and orthopedic device companies: